Ruiying Liang
Hebei Key Laboratory Of Analysis And Control Of Zoonotic Pathogenic Microorganism
Baoding, 071001, China
Baoding, 071001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Design, synthesis and biological evaluation of novel triarylmethane analogues as HIV-1 entry inhibitors.
Journal: European journal of medicinal chemistry
Published: January 19, 2025
ADS-J21 is a novel HIV-1 entry inhibitor targeting gp41.
Journal: Current research in microbial sciences
Published: August 12, 2024
Multitargeted drug design strategy for discovery of short-peptide-based HIV-1 entry inhibitors with high potency.
Journal: European journal of medicinal chemistry
Published: February 02, 2023
Supercoiling Structure-Based Design of a Trimeric Coiled-Coil Peptide with High Potency against HIV-1 and Human β-Coronavirus Infection.
Journal: Journal of medicinal chemistry
Published: April 30, 2021
Recent advances in developing small-molecule inhibitors against SARS-CoV-2.
Journal: Acta pharmaceutica Sinica. B
Published: March 20, 2021
Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.
Journal: Signal transduction and targeted therapy
Published: July 09, 2020
Influenza virus glycoprotein-reactive human monoclonal antibodies.
Journal: Microbes and infection
Published: May 01, 2020
Development of small-molecule inhibitors against hantaviruses.
Journal: Microbes and infection
Published: May 01, 2020
Recent advances in the detection of respiratory virus infection in humans.
Journal: Journal of medical virology
Published: December 23, 2019
Development of Small-Molecule Inhibitors Against Zika Virus Infection.
Journal: Frontiers in microbiology
Published: September 29, 2019
Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV.
Journal: Antibodies (Basel, Switzerland)
Published: August 22, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026